Structured evidence table for Synbiotics Metabolic Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Synbiotics Metabolic Health Randomized Trial | This narrative review summarizes current evidence on dietary and supplementation-based strategies for modulating the gut microbiota, with particular attention to dietary fiber, fermented foods, prebiotics, probiotics, synbiotics, and postbiotics. | 4 | Ekstedt-Biskot N (2026) | Dietary and Supplementation Strategies for Modulating Gut Microbiota: A Narrative Review. |
| Synbiotics Metabolic Health Randomized Trial | Overall, current evidence suggests that microbiota-targeted nutritional strategies may support gut homeostasis and selected health-related outcomes; however, their effects are not universal and require more personalized and better-controlled approaches in future research. | 4 | Ekstedt-Biskot N (2026) | Dietary and Supplementation Strategies for Modulating Gut Microbiota: A Narrative Review. |
| Synbiotics Metabolic Health Randomized Trial | The composition and balance of the gut microbiota are important for human health, as they are involved in metabolic processes, immune regulation, intestinal barrier function, and gut-brain communication. | 4 | Ekstedt-Biskot N (2026) | Dietary and Supplementation Strategies for Modulating Gut Microbiota: A Narrative Review. |
| Synbiotics Metabolic Health Randomized Trial | India's escalating burden of obesity and metabolic disease is characterized by a distinctive "thin-fat" phenotype, in which individuals with normal or near-normal body mass index exhibit disproportionate visceral adiposity, reduced skeletal muscle mass, and heightened susceptibility to insulin resistance. | 4 | Ganguly NK (2026) | Reconsidering Obesity in India Through a Gut-Metabolic Lens: Mechanistic Insights and the Emerging Role of Synbiotics in Individuals with the Thin-Fat Phenotype. |
| Synbiotics Metabolic Health Randomized Trial | Emerging evidence implicates gut microbiome dysbiosis, impaired fermentation of dietary fibers, reduced short-chain fatty acid (SCFA) signaling, altered bile acid metabolism, metabolic endotoxemia, and dysregulated adipose tissue crosstalk as key contributors to metabolic vulnerability in South Asian populations. | 4 | Ganguly NK (2026) | Reconsidering Obesity in India Through a Gut-Metabolic Lens: Mechanistic Insights and the Emerging Role of Synbiotics in Individuals with the Thin-Fat Phenotype. |
| Synbiotics Metabolic Health Randomized Trial | Emerging clinical evidence from randomized controlled trials evaluating synbiotic and prebiotic-botanical formulations is also discussed, highlighting their potential benefits as adjuncts to lifestyle modification. | 4 | Ganguly NK (2026) | Reconsidering Obesity in India Through a Gut-Metabolic Lens: Mechanistic Insights and the Emerging Role of Synbiotics in Individuals with the Thin-Fat Phenotype. |
| Synbiotics Metabolic Health Randomized Trial | Conventional obesity models centered primarily on caloric imbalance fail to adequately explain this pattern, underscoring the need for a more integrative pathophysiological framework. | 4 | Ganguly NK (2026) | Reconsidering Obesity in India Through a Gut-Metabolic Lens: Mechanistic Insights and the Emerging Role of Synbiotics in Individuals with the Thin-Fat Phenotype. |
Source documents